Remdesivir-ivermectin combination displays synergistic interaction with improved in vitro antiviral activity against SARS-CoV-2 (2020)
Attributed to:
Tropical Infectious Disease Consortium: Expanding and Accelerating Product
Development
funded by
UKRI
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.12.23.424232
Publication URI: http://dx.doi.org/10.1101/2020.12.23.424232
Type: Preprint